Industry Insights
Stay informed to stay ahead of your competition with the latest industry trends and insights.
8 feeds
297 followers
50 아티클/주
Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy
Lilly joins OAC campaign against obesity stigma, partnering on gallery of bias-free images for use in media coverage
EU drug reviewers back Novo Nordisk’s FDA-rejected hemophilia drug, snub PTC’s Translarna again
Baxter to import 18,000 tons of IV product by year-end as hurricane recovery efforts continue in NC
321 followers
50 아티클/주
Intuitive Surgical stock surges 10% amid da Vinci 5 demand, with full rollout set for 2025
GSK and Boston scientists team up to study pulmonary fibrosis and develop new treatments
BioNTech-OncoC4 phase 3 cancer trial under partial hold after varying results reported
Supernus links depression drug to fast responses in phase 2 trial
Reporting from the frontiers of health and medicine
618 followers
73 아티클/주
Contains all the PharmaTimes latest World News.
320 followers
7 아티클/주
Pharmaceuticals news and pharmaceutical industry analysis - FT.com
따르다The latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
The latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
500 followers
12 아티클/주
BioPharma
317 followers
26 아티클/주
459 followers
2 아티클/주
Events
311 followers
3 아티클/주
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 October 2024
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)14-17 October 2024
Translarna: EMA re-confirms non-renewal of authorisation of Duchenne muscular dystrophy medicine
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 October 2024